Lactic acid bacteria and use thereof
AssigneesUniversity-Industry Cooperation Group of Kyung Hee University, Navipharm Co., Ltd.
InventorsDong-Hyun Kim, Myung Joo Han
Life of this patent
Estimating the term…
Abstract
The present invention relates to a novel lactic acid bacterium, and more particularly, to a composition comprising Lactobacillus reuteri NK33 (KCCM12090P) or Bifidobacterium adolescentis NK98 (KCCM12297P), which is the novel lactic acid bacterium, useful in preventing and treating a neurological mental disease or an inflammatory disease. Also, the present invention relates to a composition for diagnosing a neurological mental disease, comprising a preparation for measuring a level of an intestinal microorganism, a kit comprising the same, and a method for diagnosing the neurological mental disease, comprising a step of measuring the level of the intestinal microorganism.
Claims8
A method for treating a mental disorder or an inflammatory disease, comprising:
- administering a pharmaceutical composition comprising Lactobacillus reuteri NK33 (KCCM12090P) into a subject,
- wherein the inflammatory disease is colitis, and
- wherein the mental disorder is one or more selected from the group consist of anxiety, depression, and stress.
A method for alleviating a mental disorder or an inflammatory disease, comprising:
- administering a health functional food comprising Lactobacillus reuteri NK33 (KCCM12090P) into a subject,
- wherein the inflammatory disease is colitis, and
- wherein the mental disorder is one or more selected from the group consist of anxiety, depression, and stress.
Dependencies are inferred from the claim text.